Inquiry
Form loading...

Featured POCT & Diagnostic Reagent Exhibitors

2025-07-01

Here are the standout players in POCT (Point-of-Care Testing) and rapiD Diagnostic reagents showcased at WHX Miami 2025, with a spotlight on innovative immunoassay solutions akin to alternating static immuno protocols (e.g., rapid antigen/antibody tests):

Drugs of abuse.png


🔬 Featured POCT & Diagnostic Reagent Exhibitors

🧪 ABOUND Diagnostics Inc. (Booth J94)

American firm offering a comprehensive lineup of FDA 510(k)-cleared Rapid Tests, including:

 

Women’s health (e.g., early pregnancy hCG)

Drugs of abuse

Infectious diseases

Cardiac and tumor markers

Supports both professional and home-use POCT with strong OEM & contract manufacturing capabilities.

Why it matters: Their kits align closely with rapid immuno-assay workflows, similar to the alternating static immuno protocols used in emergency and decentralized testing.

 

🌍 Atlas Medical GmbH (Booth H52)

German-based specialist in diagnostic reagents and kits spanning serology, immunology, clinical chemistry, ELISA, and lateral flow rapid tests

Why it matters: Their lateral flow platforms, based on nano-bead serology and immunoassay formats, are ideal for rapid, high-sensitivity point-of-care applications, comparable to alternating static immuno mechanisms.

🧬 Biobase (China) (Booth W17)

Infectious diseases.png
Showcased PCR reagent systems, nucleic acid extraction kits, and rapid COVID‑19 detection tools.

Why it matters: Their nucleic acid-based kits complement immuno POCT by offering confirmatory testing—ideal in combined rapid-testing workflows.

 

⚙️ Technical & Functional Highlights

Rapid Immunoassays (Lateral Flow): Integral to both ABOUND and Atlas Medical’s offerings, providing quick results in clinical or field settings.

Multi-marker Panels: ABOUND’s tests cover diverse analytes (infectious, hormonal, drug, cardiac), enabling multiplex POCT workflows.

Advanced Reagent Platforms: Atlas Medical’s expertise in nano-bead and ELISA systems supports high-performance lateral flow and static immuno steps typical of alternating antigen/antibody incubations.

POC + Lab Confirmation: Biobase’s nucleic-acid kits serve as fast lab or field extensions to immuno POCT, ensuring workflow versatility.

 Cardiac and tumor markers.png

✅ Conclusion

WHX Miami 2025 showcased a robust range of diagnostic reagent and POCT innovations, especially in rapid immunoassay formats.

If you’re specifically interested in alternating static immuno formats (e.g., protocols with multiple binding/incubation stages like some rapid antigen/antibody kits), both ABOUND and Atlas Medical offer fitting solutions. Atlas, in particular, has deep expertise in lateral flow and ELISA that can serve as a foundation for these types of workflows.